Quadrature Capital’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Other funds holding CABA
VCM
Quadrature Capital's CABA Position: Q2 2026 in Review
Quadrature Capital sold out of Cabaletta Bio (CABA) in Q2 2026, closing a stake of 87,060 shares — an estimated $234K sold.
Quadrature Capital first reported a position in CABA in Q3 2025 and held it in 3 quarters. The position peaked at $234K in Q1 2026. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2026.
- Quadrature Capital reported no remaining Cabaletta Bio position as of Q2 2026 after selling out during the quarter.
- Quadrature Capital sold 87,060 Cabaletta Bio shares in Q2 2026, an estimated $234K.
- Quadrature Capital first reported a position in Cabaletta Bio in Q3 2025 and held it in 3 quarters.
- Quadrature Capital's Cabaletta Bio position peaked at $234K in Q1 2026.
- 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.
Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.